Janus kinase 2 inhibition by pacritinib as potential therapeutic target for liver fibrosis.

Hepatology (Baltimore, Md.)（2023）

引用 5|浏览35

暂无评分

摘要

This study demonstrates that the JAK2 inhibitor pacritinib may be promising for the treatment of alcoholic and nonalcoholic liver fibrosis and may be therefore relevant for human pathology.

查看译文

关键词

liver fibrosis,pacritinib,potential therapeutic target,therapeutic target,janus

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要